At a press conference during the ASCO 2012 Annual Meeting in Chicage, June 1st - June 4th, Dr Ellen Lavoie Smith presented findings from a phase III study where it was discovered that duloxetine is effective in treating painful chemotherapy-induced peripheral neuropathy.

This finding will likely change oncology practice and offers an important new quality of life solution for patients.